Media centre

Press releases

To be notified when a new press release is added to this site please register with our alert service.

•  2008 
•  2007 
•  2006 
•  2005 
•  2004 
•  2003 
•  2002 

Date	Title
15/12/2006	Antisoma raises £26.3 million in oversubscribed placing to European and U.S. institutions
11/12/2006	Antisoma advancing AS1411 into phase II in acute myelogenous leukaemia; positive supporting data presented at ASH
15/11/2006	Antisoma plc Annual Information Update
08/11/2006	Positive data from Antisoma’s AS1404 lung cancer trial presented at conference
16/10/2006	Antisoma’s preliminary results for the year ended 30 June 2006
16/10/2006	Antisoma presents positive tumour response data from AS1404 phase II trial in ovarian cancer
02/10/2006	Antisoma announces positive phase I data on AS1411, plans phase II trials in renal and blood cancers
27/09/2006	Final data from Antisoma’s AS1404 lung cancer trial show clear survival benefit
18/09/2006	Antisoma presents positive PSA data from AS1404 phase II trial in prostate cancer
12/09/2006	Antisoma’s AS1404 successfully combined with Erbitux in preclinical study
11/09/2006	New data explain cancer cell killing by AS1402
05/09/2006	Second dramatic response seen with Antisoma’s AS1411 in renal cancer
29/08/2006	Antisoma selects renal cancer and melanoma as phase I indications for AS1409
04/06/2006	Antisoma's AS1404 shows early promise in ovarian cancer trial
04/06/2006	Antisoma reports survival advantage for AS1404 in lung cancer and regains product rights
04/06/2006	Antisoma announces positive phase I data, new trial plans and regaining of rights for R1550
24/04/2006	Antisoma appoints Dr Gary Acton as Chief Medical Officer
04/04/2006	Positive preclinical data on Antisoma’s AS1411 presented at AACR
03/04/2006	Antisoma’s AS1404 enhances effectiveness of Avastin in colon and lung cancer models
07/03/2006	Antisoma to evaluate rainforest anti-cancer compounds from EcoBiotics Ltd
Page 1  2    >>